Literature DB >> 20472505

Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

R Zemble1, E Luning Prak, K McDonald, D McDonald-McGinn, E Zackai, K Sullivan.   

Abstract

Clinical evidence suggests that patients with Chromosome 22q11.2 deletion (Ch22q11.2D) have an increased prevalence of atopic and autoimmune disease and this has been without explanation. We hypothesized that the increase in atopy was due to homeostatic proliferation of T cells leading to a Th2 skew. We performed intracellular cytokine staining to define Th1/Th2 phenotypes in toddlers (early homeostatic proliferation) and adults (post homeostatic proliferation) with this syndrome. To attempt to understand the predisposition to autoimmunity we performed immunophenotyping analyses to define Th17 cells and B cell subsets. Adult Ch22q11.2D patients had a higher percentage of IL-4+CD4+ T cells than controls. Th17 cells were no different in patients and controls. In addition, adult Ch22q11.2D syndrome patients had significantly lower switched memory B cells, suggesting a dysregulated B cell compartment. These studies demonstrate that the decrement in T cell production has secondary consequences in the immune system, which could mold the patients' clinical picture. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20472505      PMCID: PMC2917481          DOI: 10.1016/j.clim.2010.04.011

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  79 in total

1.  Spontaneous proliferation, a response of naive CD4 T cells determined by the diversity of the memory cell repertoire.

Authors:  Booki Min; Gilles Foucras; Martin Meier-Schellersheim; William E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-04       Impact factor: 11.205

2.  Hypogammaglobulinaemia in DiGeorge sequence.

Authors:  A Etzioni; S Pollack
Journal:  Eur J Pediatr       Date:  1989-11       Impact factor: 3.183

3.  The DiGeorge sequence. II. Immunologic findings in partial and complete forms of the disorder.

Authors:  W Müller; H H Peter; H C Kallfelz; A Franz; C H Rieger
Journal:  Eur J Pediatr       Date:  1989-11       Impact factor: 3.183

4.  Prediction of persistent immunodeficiency in the DiGeorge anomaly.

Authors:  J Bastian; S Law; L Vogler; A Lawton; H Herrod; S Anderson; S Horowitz; R Hong
Journal:  J Pediatr       Date:  1989-09       Impact factor: 4.406

5.  Monosomy 22 with humoral immunodeficiency: is there an immunoglobulin chain deficit?

Authors:  J L García Miranda; A Otero Gómez; H Varela Ansedes; N Rancel Torres; C González Espinosa; C Cortabarría; G Sánchez Salgado
Journal:  J Med Genet       Date:  1983-02       Impact factor: 6.318

Review 6.  The DiGeorge syndrome. I. Clinical evaluation and course of partial and complete forms of the syndrome.

Authors:  W Müller; H H Peter; M Wilken; H Jüppner; H C Kallfelz; H P Krohn; K Miller; C H Rieger
Journal:  Eur J Pediatr       Date:  1988-06       Impact factor: 3.183

7.  Homeostatic expansion of T cells during immune insufficiency generates autoimmunity.

Authors:  Cecile King; Alex Ilic; Kersten Koelsch; Nora Sarvetnick
Journal:  Cell       Date:  2004-04-16       Impact factor: 41.582

8.  Selective polysaccharide antibody deficiency in familial DiGeorge syndrome.

Authors:  M S Schubert; R B Moss
Journal:  Ann Allergy       Date:  1992-09

9.  Clinical and immunologic spectrum of the DiGeorge syndrome.

Authors:  D J Barrett; A J Ammann; D W Wara; M J Cowan; T J Fisher; E R Stiehm
Journal:  J Clin Lab Immunol       Date:  1981-07

10.  The spectrum of the DiGeorge syndrome.

Authors:  M E Conley; J B Beckwith; J F Mancer; L Tenckhoff
Journal:  J Pediatr       Date:  1979-06       Impact factor: 4.406

View more
  28 in total

Review 1.  New frontiers in primary immunodeficiency disorders: immunology and beyond….

Authors:  Eleonora Gambineri
Journal:  Cell Mol Life Sci       Date:  2011-10-19       Impact factor: 9.261

2.  Transgenic expression of microRNA-185 causes a developmental arrest of T cells by targeting multiple genes including Mzb1.

Authors:  Serkan Belkaya; Sean E Murray; Jennifer L Eitson; M Teresa de la Morena; James A Forman; Nicolai S C van Oers
Journal:  J Biol Chem       Date:  2013-09-06       Impact factor: 5.157

3.  Congenital anomalies and rhabdoid tumor associated with 22q11 germline deletion and somatic inactivation of the SMARCB1 tumor suppressor.

Authors:  George Toth; Claudia B Zraly; Tricia L Thomson; Carolyn Jones; Shawn Lapetino; Jonathan Muraskas; Jiwang Zhang; Andrew K Dingwall
Journal:  Genes Chromosomes Cancer       Date:  2011-03-15       Impact factor: 5.006

Review 4.  Immunological aspects of 22q11.2 deletion syndrome.

Authors:  A R Gennery
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

Review 5.  Head and neck manifestations of 22q11.2 deletion syndromes.

Authors:  Tal Marom; Yehudah Roth; Abraham Goldfarb; Udi Cinamon
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-08-23       Impact factor: 2.503

6.  A pilot study on immuno-psychiatry in the 22q11.2 deletion syndrome: A role for Th17 cells in psychosis?

Authors:  Elfi Vergaelen; Carmen Schiweck; Kristof Van Steeland; Jacqueline Counotte; Wim Veling; Ann Swillen; Hemmo Drexhage; Stephan Claes
Journal:  Brain Behav Immun       Date:  2018-03-19       Impact factor: 7.217

Review 7.  Immunodeficiencies Associated with Abnormal Newborn Screening for T Cell and B Cell Lymphopenia.

Authors:  Soma Jyonouchi; Artemio M Jongco; Jennifer Puck; Kathleen E Sullivan
Journal:  J Clin Immunol       Date:  2017-03-28       Impact factor: 8.317

8.  Adoptive transfer of autologous T cells improves T-cell repertoire diversity and long-term B-cell function in pediatric patients with neuroblastoma.

Authors:  Stephan A Grupp; Eline Luning Prak; Jean Boyer; Kenyetta R McDonald; Suzanne Shusterman; Edward Thompson; Colleen Callahan; Abbas F Jawad; Bruce L Levine; Carl H June; Kathleen E Sullivan
Journal:  Clin Cancer Res       Date:  2012-10-23       Impact factor: 12.531

9.  Signature MicroRNA expression patterns identified in humans with 22q11.2 deletion/DiGeorge syndrome.

Authors:  M Teresa de la Morena; Jennifer L Eitson; Igor M Dozmorov; Serkan Belkaya; Ashley R Hoover; Esperanza Anguiano; M Virginia Pascual; Nicolai S C van Oers
Journal:  Clin Immunol       Date:  2013-01-30       Impact factor: 3.969

Review 10.  22q11.2 deletion syndrome.

Authors:  Donna M McDonald-McGinn; Kathleen E Sullivan; Bruno Marino; Nicole Philip; Ann Swillen; Jacob A S Vorstman; Elaine H Zackai; Beverly S Emanuel; Joris R Vermeesch; Bernice E Morrow; Peter J Scambler; Anne S Bassett
Journal:  Nat Rev Dis Primers       Date:  2015-11-19       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.